In conclusion, liraglutide (Saxenda) is approved for adults with a BMI of 30 kg/m2 or greater, or a BMI of 27 kg/m2 or greater with at least one weight-related condition, as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management
"However, if symptoms persist or worsen, it may be necessary to discontinue the medication." But if this is more about skin changes, Goldenberg says it's crucial to focus on internal and external hydrationmeaning, drink plenty of water and grab an unscented moisturizer
Always speak to your healthcare provider if you feel like you cant eat enough calories on your weight loss medication
Any significant change from baselineparticularly the development of bloody stools, nocturnal diarrhea awakening them from sleep, or progressive worsening of symptomswarrants prompt clinical assessment
Inhaled insulin in patients with asthma and chronic obstructive pulmonary disease
Suggested use: Gently shake before use